In reponse to: Optimization of antiviral prescribing for influenza

We thank Dr. Aldaja for the comments on our work. We agree that delays in laboratory diagnosis, and the inability to identify influenza viral subtype may further undermine the low rates of appropriate prescription of oseltamivir noted in our study. Additionally, we also suspect that improved diagnostic and treatment practices for patients with seasonal influenza are likely to benefit patients if an influenza pandemic were to arise.